Daiichi Sankyo Company, Limited (TYO:4568)
2,729.00
-41.00 (-1.48%)
Aug 14, 2026, 3:30 PM JST
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 20,171 employees as of March 31, 2026. The number of employees increased by 406 or 2.05% compared to the previous year.
Employees
20,171
Change (1Y)
406
Growth (1Y)
2.05%
Revenue / Employee
110.22M JPY
Profits / Employee
12.05M JPY
Market Cap
4.97T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 20,171 | 406 | 2.05% |
| Mar 31, 2025 | 19,765 | 1,039 | 5.55% |
| Mar 31, 2024 | 18,726 | 1,291 | 7.40% |
| Mar 31, 2023 | 17,435 | 977 | 5.94% |
| Mar 31, 2022 | 16,458 | 425 | 2.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Otsuka Holdings | 37,758 |
| Astellas Pharma | 14,099 |
| Kyowa Kirin | 5,173 |
| Chugai Pharmaceutical | 5,104 |
| Ono Pharmaceutical | 4,206 |
| Santen Pharmaceutical | 3,968 |
| JCR Pharmaceuticals | 985 |
| Perseus Proteomics | 35 |
Daiichi Sankyo Company News
- 5 days ago - Innovent, Daiichi Sankyo Ink China Deal For VANFLYTA Commercialization - Nasdaq
- 5 days ago - Innovent Biologics Secures China Commercialization Rights For Vanflyta In Deal With Daiichi Sankyo - Nasdaq
- 5 days ago - Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China - PRNewsWire
- 15 days ago - Q1 2027 Daiichi Sankyo Co Ltd Earnings Presentation (Japanese) Transcript - GuruFocus
- 15 days ago - Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results - Business Wire
- 15 days ago - Daiichi Sankyo Company Earnings Call Transcript: Q1 2027 - Transcripts
- 15 days ago - Daiichi Sankyo Company Quarterly report: Q1 2027 - Filings
- 15 days ago - Daiichi Sankyo Company Slides: Q1 2027 - Filings